Nucleic acid aptamers stabilize proteins against different types of stress conditions.

It has been observed that the same osmolyte cannot provide protection to a protein exposed to more than one stress condition. We wanted to study the effect of nucleic acid aptamers on the stabilization of proteins against a variety of stress conditions. Adjuvanted tetanus toxoid was exposed to thermal, freeze-thawing, and agitation stress. The stability and antigenicity of the toxoid were measured. Using nucleic acid aptamers selected against tetanus toxoid, we show that these specific RNA sequences were able to stabilize alumina-adsorbed tetanus toxoid against thermal-, agitation-, and freeze-thawing-induced stress. Binding affinity of the aptamer-protein complex did not show any significant change at elevated temperature as compared with that at room temperature, indicating that the aptamer protected the protein by remaining bound to it under stress conditions and did not allow either the protein to unfold or to promote protein-protein interaction. Thus, we show that by changing the stabilization strategy from a solvent-centric to a protein-centric approach, the same molecule can be employed as a stabilizer against more than one stress condition and thus probably reduce the cost of the product during its formulation.

[1]  Ipsita Roy,et al.  Probing the mechanism of insulin aggregation during agitation. , 2011, International journal of pharmaceutics.

[2]  N. Jain,et al.  Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing. , 2011, International journal of pharmaceutics.

[3]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[4]  Ipsita Roy,et al.  Stabilization of bovine insulin against agitation-induced aggregation using RNA aptamers. , 2013, International journal of pharmaceutics.

[5]  Theodore W Randolph,et al.  Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. , 2012, Journal of pharmaceutical sciences.

[6]  S. N. Timasheff,et al.  Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Singh,et al.  Determinants of immunogenic response to protein therapeutics. , 2012, Biologicals : journal of the International Association of Biological Standardization.

[8]  I. Roy,et al.  Effect of trehalose on protein structure , 2008, Protein science : a publication of the Protein Society.

[9]  Ipsita Roy,et al.  Nucleic Acid Aptamers as Stabilizers of Proteins: The Stability of Tetanus Toxoid , 2013, Pharmaceutical Research.

[10]  Thomas W. Patapoff,et al.  Opposite Effects of Polyols on Antibody Aggregation: Thermal Versus Mechanical Stresses , 2011, Pharmaceutical Research.

[11]  Alain Pluen,et al.  Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregation. , 2013, Trends in biotechnology.

[12]  Charles Tanford,et al.  Isothermal Unfolding of Globular Proteins in Aqueous Urea Solutions , 1964 .

[13]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[14]  N. Jain,et al.  Accelerated Stability Studies for Moisture-Induced Aggregation of Tetanus Toxoid , 2011, Pharmaceutical Research.

[15]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[16]  A. Barbosa‐Póvoa Supply chain , 2015, 2015 International Conference on Industrial Engineering and Systems Management (IESM).

[17]  W. Hinrichs,et al.  Unraveling protein stabilization mechanisms: vitrification and water replacement in a glass transition temperature controlled system. , 2013, Biochimica et biophysica acta.

[18]  B. Narasimhan,et al.  Protein stability in the presence of polymer degradation products: consequences for controlled release formulations. , 2006, Biomaterials.

[19]  N. Jain,et al.  Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation. , 2012, International journal of pharmaceutics.

[20]  J. Lee,et al.  The stabilization of proteins by sucrose. , 1981, The Journal of biological chemistry.

[21]  S. Tope,et al.  Aptamers as therapeutics , 2013 .

[22]  David Ouellette,et al.  Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? , 2005, Journal of pharmaceutical sciences.

[23]  D. W. Bolen,et al.  Osmolyte effects on protein stability and solubility: a balancing act between backbone and side-chains. , 2011, Biophysical chemistry.

[24]  R. Rodrigues,et al.  Effect of the support size on the properties of β-galactosidase immobilized on chitosan: advantages and disadvantages of macro and nanoparticles. , 2012, Biomacromolecules.

[25]  H. Wibisono,et al.  Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. , 2004, Bulletin of the World Health Organization.

[26]  I. Roy,et al.  Therapeutic applications of aptamers , 2008, Expert opinion on investigational drugs.

[27]  A. Khan,et al.  Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries - a systematic review , 2013, BMC Public Health.

[28]  G. W. Robinson,et al.  Understanding all of water’s anomalies with a nonlocal potential , 1997 .

[29]  Shawn T. Brown,et al.  The impact of making vaccines thermostable in Niger's vaccine supply chain. , 2012, Vaccine.

[30]  J. Carpenter,et al.  Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. , 2008, Journal of pharmaceutical sciences.

[31]  R. Karimov,et al.  A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS) , 2011, BMC public health.

[32]  R. Bhat,et al.  Why Is Trehalose an Exceptional Protein Stabilizer? , 2003, Journal of Biological Chemistry.

[33]  Jayashree Subramanian,et al.  Culture temperature modulates aggregation of recombinant antibody in cho cells , 2012, Biotechnology and bioengineering.

[34]  Hanns-Christian Mahler,et al.  The Degradation of Polysorbates 20 and 80 and its Potential Impact on the Stability of Biotherapeutics , 2011, Pharmaceutical Research.

[35]  Debra Kristensen,et al.  Stabilization of vaccines: Lessons learned , 2010, Human vaccines.

[36]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[37]  Thomas W Patapoff,et al.  Solubilities and transfer free energies of hydrophobic amino acids in polyol solutions: importance of the hydrophobicity of polyols. , 2011, Journal of pharmaceutical sciences.

[38]  M. N. Gupta,et al.  Smart biocatalysts: design and applications. , 2004, Advances in biochemical engineering/biotechnology.

[39]  Theodore W Randolph,et al.  The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study. , 2013, Journal of pharmaceutical sciences.

[40]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[41]  A. Dong,et al.  Effects of immobilization onto aluminum hydroxide particles on the thermally induced conformational behavior of three model proteins. , 2009, International journal of biological macromolecules.

[42]  M. Bathe,et al.  Designer nucleic acids to probe and program the cell. , 2012, Trends in cell biology.

[43]  Michelle M. Garrison,et al.  Freezing temperatures in the vaccine cold chain: a systematic literature review. , 2007, Vaccine.